ASSET | DATE | % RETURN |
---|---|---|
CleanSpark (CLSK) | 5/1/2015 - 6/30/2015 | 791.08% |
Sarepta Therapeutics (SRPT) | 5/1/2015 - 6/30/2015 | 148% |
Ultragenyx (RARE) | 5/1/2015 - 6/30/2015 | 78.82% |
Intracellular Th (ITCI) | 5/1/2015 - 6/30/2015 | 54.2% |
Wingstop (WING) | 5/1/2015 - 6/30/2015 | 49.47% |
Halozyme Therapeutics (HALO) | 5/1/2015 - 6/30/2015 | 49.34% |
Globant (GLOB) | 5/1/2015 - 6/30/2015 | 44.56% |
NexGen Energy (NXE) | 5/1/2015 - 6/30/2015 | 43.02% |
Amedisys (AMED) | 5/1/2015 - 6/30/2015 | 40.99% |
Blueprint Medicines (BPMC) | 5/1/2015 - 6/30/2015 | 40.98% |
EXACT Sciences (EXAS) | 5/1/2015 - 6/30/2015 | 40.95% |
Neurocrine Biosciences (NBIX) | 5/1/2015 - 6/30/2015 | 40.47% |
Ambarella (AMBA) | 5/1/2015 - 6/30/2015 | 40.02% |
Walker & Dunlop (WD) | 5/1/2015 - 6/30/2015 | 39.85% |
Amicus Therapeutics (FOLD) | 5/1/2015 - 6/30/2015 | 39.27% |
Q2 (QTWO) | 5/1/2015 - 6/30/2015 | 37.8% |
Repligen (RGEN) | 5/1/2015 - 6/30/2015 | 37.38% |
LeMaitre Vascular (LMAT) | 5/1/2015 - 6/30/2015 | 36.04% |
Exelixis (EXEL) | 5/1/2015 - 6/30/2015 | 35.74% |
QXO (QXO) | 5/1/2015 - 6/30/2015 | 34% |
Green Brick Partners (GRBK) | 5/1/2015 - 6/30/2015 | 33.21% |
Coty (COTY) | 5/1/2015 - 6/30/2015 | 33.15% |
Coca-Cola Consolidated (COKE) | 5/1/2015 - 6/30/2015 | 32.59% |
Supernus Pharmaceuticals (SUPN) | 5/1/2015 - 6/30/2015 | 31.63% |
Equinox Gold (EQX) | 5/1/2015 - 6/30/2015 | 31.38% |